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ABSTRACT
Objectives: The objectives of the study were to determine antibacterial, anti-adherence, and antibiofilm activities of Melastoma malabathricum stem 
bark acetone extract (MMSBAE) subfraction against Streptococcus mutans.
Methods: Fraction 9 (F9) from MMSBAE was subfractionated by thin-layer chromatography (TLC) and analyzed for antibacterial activity against 
S. mutans by TLC-bioautography. Subfraction 12 (SF12) was isolated from F9 followed by determination of minimum inhibitory concentration (MIC) 
and minimum bactericidal concentration (MBC) values.
Results: MIC and MBC values were 10 mg/mL and 160 mg/mL, indicating bacteriostatic property of SF12. Time-kill assay analysis confirmed 
bacteriostatic property of SF12 against S. mutans. Crystal violet staining and glass surface assays were used to determine anti-adherence and antibiofilm 
activities. Concentrations produced 50% reduction in anti-adherence and antibiofilm activities were 40 mg/mL and 20 mg/mL, respectively. Scanning 
electron microscopy was performed to visualize the effect of SF12 on S. mutans biofilm structure. SF12 was found to lyse biofilm formation on treated 
bacteria indicating powerful anticariogenic potential against S. mutans. Analysis by quantitative real-time polymerase chain reaction revealed SF12 at 
MIC value downregulated biofilm formation genes such as gbpA, brpA, gtfC, and comDE.
Conclusion: SF12 showed bacteriostatic activities against S. mutans by inhibiting adherence and biofilm activities.
Keywords: Streptococcus mutans, Subfraction, Melastoma malabathricum stem bark acetone extract, Antibiofilm activity, Anti-adherence activity.
INTRODUCTION
Streptococcus mutans is the main causative agents of dental caries 
by biofilm formation and increase adherence activities [1]. Dental 
caries problem arised due to resistance to antibiotic and antiseptic of 
the causative bacteria. Besides, some mouthwashes used to prevent 
dental caries contained high concentration of alcohol and can lead to 
oral cancer. Shekar et al. reported that natural products are a good 
alternative to control oral diseases such as dental caries and periodontal 
disease [2]. It was suggested that natural products have minor side 
effects and more importantly able to avoid development of primary or 
secondary resistance to the drug during therapy.
Melastoma malabathricum (Melastomataceae) or senduduk are used 
widely in traditional medicine including to relieve toothaches. Stem 
bark acetone extract of M. malabathricum stem bark acetone extract 
(MMSBAE) was reported previously to possess antibiofilm and anti-
adherence activity against S. mutans [3]. MMSBAE affects S. mutans 
cell membrane and wall structure which eventually leads to cell 
death. Fraction 9 (F9) from MMSBAE have been reported to show a 
large inhibition zone against S. mutans by thin-layer chromatography 
(TLC)-bioautography [4]. Therefore, in this study, a closer look of this 
subfraction was done, and the mode of action was evaluated especially 
on the antibiofilm and anti-adherence activities.
METHODS
Preparation of subfraction 12 (SF12)
Preparation of F9 was done following method describe by Hanafiah 
et al., [4]. F9 was further fractionated to 13 subfractions. Further separation 
of all the fractions was done by TLC using n-hexane:acetone (70:30).
TLC-bioautography
Antibacterial activity against S. mutans ATCC 25175 of subfractions 
from F9 was determined by TLC-bioautography according to Alwash 
et al. [5]. A subfraction designated as SF12 showed clear, unstained spot 
when 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
was added. Identification of SF12 bioactive compound was done by gas 
chromatography-mass spectrometry (GC-MS) using similar protocol 
explained in Hanafiah et al. [3].
Minimum inhibitory concentration (MIC) and minimum 
bactericidal concentration (MBC) determination
MIC and MBC values were determined according to Alwash et al. [5]. A 
total of 100 μL of S. mutans at 108 colony-forming unit (CFU)/mL were 
added to a series of SF12 concentrations (2.5–160 mg/mL) diluted in 
Mueller-Hinton broth (MHB) to a final volume of 200 μL/well. Dimethyl 
sulfoxide (DMSO) 10% (v/v) was used as negative control and penicillin 
at 0.004–0.06 mg/mL was used as positive control. Cultures were 
incubated at 37°C in anaerobic condition for 24 h. Determination of MIC 
value was done by observing the lowest concentration which inhibited 
visible growth of bacteria. Then, it is followed by determination of MBC 
by subculturing a 5 μL aliquot from MIC value onto nutrient agar and 
incubated at 37°C for 24 h. MBC was defined as the lowest concentration 
with no growth on agar plates.
Time-kill assay
The assay was done to determine the bacterial growth according to Raja 
et al. [6]. A total of 200 µL S. mutans at ~108 CFU/mL were added to 20 mL 
of MHB in conical flasks containing SF12 at different concentrations 
(1.25–40 mg/mL). The flasks were incubated at 37°C overnight. A total 
of 100 μL aliquot were removed from the flasks at several time points 
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(0, 1, 2, 4, 6, 8, 10, and 24 h) followed by streaking on Tryptic Soy Agar 
in triplicate for determination of viable bacteria count. Killing curve was 
plotted as CFU (log10 CFU/mL) versus time over 24 h period.
Anti-adherence and antibiofilm formation assays
Biofilm formation and adherence assays were done by following Khan 
et al. [7]. Briefly, 50 μL of SF12 at different concentrations (5–80 mg/mL) 
was added to S. mutans (108 CFU/mL) well. Negative control contained 
S. mutans treated with DMSO, while positive control was S. mutans 
treated with penicillin (1 mg/mL). After inoculation, all plates were 
incubated in an anaerobic incubator at 37°C for 24 h. Biofilm formation 
was determined by crystal violet assay [3]. For adherence assay, 
SF12 (5–80 mg/mL) was added to brain heart infusion broth (BHIB) 
containing S. mutans (OD595 ≈ 1) and 0.25% sucrose in a glass tube. All 
tubes were inclined at 30° and incubated at 37°C for 24 h. Turbidity of 
cells adhered to the glass slide was determined by spectrophotometer 
at 600 nm. Tests were performed in triplicate.
Scanning electron microscopy (SEM)
A total of 100 µL of SF12 (10 mg/mL) were added to 5 mL of BHIB 
containing S. mutans, then incubated at 37°C for 24 h. Cultures were 
plated on BHI agar containing 10% sucrose and incubated for 24 h at 37°C. 
Negative control of this analysis was non-treated bacteria. Agar was cut 
into 5 mm × 5 mm and washed with phosphate buffer (pH 7.1) twice. Then, 
agar was dried and treated with 4% formalin. Dehydration of samples was 
done by incubating samples in increasing percentage of alcohol (33–99%). 
Agar was finally coated with gold before observation using SEM.
Real-time polymerase chain reaction (RT-PCR)
Isolation of RNA from S. mutans treated with SF12 at MIC value and SF12 
non-treated was carried out using the SV total RNA isolation system 
(Promega, USA), according to the manufacturer’s protocol. Following 
purification, the RNA concentration was determined by measuring the 
absorbance at 260 nm (A260) on a NanoDrop 2000c spectrophotometer 
(Thermo Fisher Scientific, Waltham, MA). Complimentary DNA (cDNA) was 
synthesized using ImProm-II™ reverse transcription system (Promega, 
USA). Standard reaction mixture with a total volume of 20 mL for RT was 
prepared to contain 10 mM dNTPs, 25 mM MgCl2, RNAase inhibitor, RT 
200 U, oligo-dt 0.5 µg, and 1 mg total RNA from respective samples. First 
strand complementary DNA (cDNA) was amplified following incubation 
for 90 min at 42°C and 15 min at 72°°C. The cDNA samples were stored 
at −20°°C until further use. RT-PCR was done using SensiFAST™ SYBR and 
Fluorescein kit (Bioline, USA). Primers gbpA, brpA, gtfC, and comDE were 
used following the suggestion in Hasan et al. [8]. PCR condition consists 
of cDNA denaturation at 95°°C for 2 min, 40-cycles of amplification 
consisting of 5 s denaturation at 95°°C, annealing, and extension at 60°°C 
for 15 s. The expression levels of biofilm genes were normalized against 
S. mutans 16S rRNA as a reference gene [8]. The relative quantification 
model by Livak and Schmittgen was used for determination of mRNA fold 
change after normalization to internal control [9].
Statistical analysis
The effect of SF12 on biofilms and adherence was analyzed statistically 




F9 was reported by Hanafiah et al. as the most active fraction in MMSBAE 
in inhibiting S. mutans [4]. Further fractionation of F9 by HPLC eluted 
13 SF with SF12 showed clear inhibition spot against S. mutans by TLC-
bioautography (Fig. 1). MIC value for SF12 was 10 mg/mL while MBC 
was 160 mg/mL.
Time-kill assay curve
Fig. 2 showed time-kill assay curve of SF12 against S. mutans. From 
this assay, SF12 displayed bacteriostatic activity due to reduce colony 
number of <3 log10 of CFU from the initial inoculum following incubation 
for 10 h with SF12 at 10–40 mg/mL concentrations. No growth 
inhibition was determined at 1.25–5 mg/mL of SF12. Initial exposure 
to SF12 at 2.5 mg/mL and 5 mg/mL caused no S. mutans growth, but 
re-growth was detected after 4 h of treatment.
Anti-adherence and antibiofilm activities
Fig. 3 showed significant (p<0.05) anti-adherence activity of SF12 at all 
tested concentrations toward S. mutans in a dose-dependent manner. 
Biofilm formation of S. mutans reduced significantly in concentration-
dependent manner when it treated with SF12 (Fig. 4). Treatment with 
80 mg/mL of SF12 inhibited 70% biofilm formation compared to only 
20% at MIC value (10 mg/mL). DMSO did not inhibit biofilm formation 
of S. mutans, while penicillin reduced 85% of biofilm formation when 
compared to non-treated bacteria.
Morphological change of SF12 toward S. mutans
Fig. 5a showed SF12 at MIC value disrupted S. mutans chain formation 
causing scattered cells and loss of aggregation. Changes in the structure of 
treated bacteria were also noted from coccus to elongated and ellipsoid. 
Treated cells have rough surfaces, and the exopolysaccharide matrix 
was almost absent suggesting reduction in synthesis peptidoglycan. 
In comparison, non-treated bacteria surfaces have smoother coccus 
shaped and aggregated within intact exopolysaccharide matrix (Fig. 5b).
Expression of gbpA, brpA, gtfC, and comDE genes
RT-PCR analysis showed SF12 downregulated the expression of all 
selected biofilm genes: gbpA, brpA, gtfC, and comDE (Table 1). The 
Fig. 1: Subfraction 12 inhibition zone on thin-layer 
chromatography-bioautography analysis
Fig. 2: Time-kill assay curve of subfraction 12 with various 
concentrations against Streptococcus mutans. Non-treated 
bacteria served as control. Each time point represents the mean 
of three different experiments performed in triplicate. A number 
of treated S. mutans were significantly lowered (p<0.05) when 
compared to a number of non-treated S. mutans
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regulation expression level of those genes was important to determine 
the mechanism of action of SF12 on biofilm formation and quorum 
sensing (QS) process.
DISCUSSION
According to NCCLS, antibiotics with MBC value which equal to or >4 
times MIC value can be considered as bacteriostatic. SF12 showed 
bacteriostatic property in contrast to the antibacterial activity of 
crude MMSBAE [3]. According to Pankey and Sabath [10], relying on 
the determination of MIC and MBC values only to confirm antibacterial 
activities may not be accurate. Therefore, time-kill assay analysis was 
done to confirm SF12 bacteriostatic activity of S. mutans. According to 
NCCLS [11], bactericidal activity can be defined as an antibacterial agent 
which reduced CFU >3 log10 from the initial inoculum. Bacteriostatic 
activity was defined when the antibacterial agents able to reduce 
<3 log10 of CFU from the initial inoculum. This observation confirms the 
bacteriostatic nature of SF12 as determined from MIC and MBC values.
The initial stage of biofilm formation was adherence of bacteria. 
According to Sandasi et al., herbs and plant extracts reduced surface 
adherence and caused detachment of bacteria followed by antibiofilm 
activity in Listeria monocytogenes [12]. In this study, pre-treatment of 
cells with SF12 reduced adherence activity, and this was followed by 
inhibition of biofilm formation in a concentration-dependent manner. 
However, MMSBAE reduced biofilm formation of S. mutans at lower 
concentration compared to SF12 [3]. For example, MMSBAE reduced 
50% biofilm formation at 1.88 mg/mL compare to SF12 which 
reduced 50% biofilm formation at 40 mg/mL. To further understand 
this observation, a morphological study of SF12 treated bacteria was 
performed by SEM. Bacteria was scattered and loss of aggregation due 
to activity of SF12 on membrane cell. SF12 contained antibacterial 
properties and disrupted the chain formation in S. mutans.
Streptococcal cell wall was made up of four major polymers including 
peptidoglycan, protein, group and type-specific polysaccharides, and 
glycerol form of teichoic and lipoteichoic acids [13]. From GC-MS 
result, SF12 was determined to contain a-amyrin, g-sitosterol, stearic 
acid, and hexacosanoic acid (raw data not shown). Sitosterol has 
been proven to possess antimicrobial property [3,14]. Hexacosanoic 
acid also known as cerotic acid is a long chain saturated fatty acid 
with not much report in antibacterial activity. However, according to 
Giacaman et al., stearic acid does not cause a reduction in S. mutans 
colony and insoluble extracellular polysaccharide production [15]. To 
date, there are no reports on a-amyrin in antibacterial activity. Reduced 
phytochemical content in SF12 compared to MMSBAE might explain 
the loss in bactericidal activity but retained bacteriostatic properties. 
In addition, the anti-adhesiveness property of SF12 shown in this study 
is the main bacteriostatic strategy against S. mutans. This conclusion 
can be made from scientific evidence that phytochemicals can exert 
significant multiple anti-streptococcal effects and apart from their 
bactericidal effect as reviewed in Abachi et al. [16]. To further elucidate 
the molecular mechanism of SF 12 toward S. mutans, the effect on 
expression of biofilm genes was determined by RT-PCR.
RT-PCR analysis revealed that genes involved in biofilm and QS were 
downregulated when S. mutans treated with SF12. The gbpA gene was 
known to be involved in glucose binding protein during the fermentation 
of sucrose [1]. As for brpA, it plays a critical role in biofilm formation and 
the structural integrity. Depression of these genes will lead to impaired 
acid tolerance and major structural defects in biofilm formation and 
integrity, resulting in impaired virulence expressions. Reduction in 
the expression of these genes supported the SEM observation in SF12 
treated cells where exopolysaccharide matrix was found to be reduced.
The gtfC gene encodes for glucosyltransferases catalyzes the synthesis 
of water-soluble and water-insoluble glucan from sucrose [8]. 
Reduction in the expression of this gene with several other genes will 
suppress the series of cascades involved in biofilm formation, cell wall 
integrity, adhesion promotion, and surface biogenesis. The regulatory 
gene comDE is a part of the quorum-sensing cascade of S. mutans. 
Downregulation of this gene attenuated the internal communication 
system utilized by the bacteria to alter their gene expression at a critical 
cell density, which may lead to cell death [17].
A lot of resistant bacteria have been reported which lead to an increment 
of caries incident [18]. As a strategy to overcome this problem, 
Fig. 3: Adherence inhibition activity of subfraction 12 against 
Streptococcus mutans. All concentrations tested showed significant 
(p<0.05) decrease in biofilm formation compared to control
Fig. 4: Biofilm inhibition activity of subfraction 12 against 
Streptococcus mutans. All concentrations tested showed significant 
(p<0.05) decrease in biofilm formation compared to control
Table 1: Relative fold change in gene expression of S. mutans 
biofilm-related genes in cells treated with SF12 (10 mg/mL) 
normalized against S. mutans 16S rRNA as reference gene





SF12: Subfraction 12, S. mutans: Streptococcus mutans
Fig. 5: Streptococcus mutans and biofilm structures when treated 
with subfraction 12 (SF12) at 10 mg/mL (a) and not treated with 
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phytochemicals have been suggested as a new source to interfere with 
bacterial signaling pathways through QS and perhaps as chelating 
agents and efflux pump inhibitors [19]. There are lots of recent studies 
reported medicinal plant extract to possess anti-QS, anti-adherence, 
antibiofilm, antiproliferative, and antibacteria properties against oral 
bacteria [20-23]. SF12 has been shown to display the characteristics in 
anti-adherence and antibiofilm activities which may contribute to the 
use of M. malabathricum in controlling dental caries.
CONCLUSION
SF12 showed bacteriostatic activities against S. mutans by inhibiting 
biofilm formation and adherence activities in dose-dependent manner 
(p˂0.05). Downregulation of biofilm producing genes such as gbpA, 
brpA, gtfC, and comDE contributed to the reduction in QS, adherence 
activities which leads to an inhibition in biofilm formation and 
disruption in the structural integrity.
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